Evidence map›Paper›PMID 40417833›Full record

ReviewChembiochem : a European journal of chemical biology2025

Chemical Switching: A Concept Inspired by Strategies from Biocatalysis and Organocatalysis.

Torkild Visnes, Kaixin Zhou, Aurino M Kemas, Dominic Campopiano, Volker M Lauschke, Maurice Michel

Abstract readReview
In one paragraph

Review in Chembiochem : a European journal of chemical biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Torkild VisnesDepartment of Biotechnology and Nanomedicine, SINTEF, N-7465, Trondheim, Norway.
Kaixin ZhouSchool of Chemistry, University of Edinburgh, Edinburgh, EH9 3FJ, UK.
Aurino M KemasCenter for Molecular Medicine, Karolinska Institute and Karolinska Hospital, 171 76, Stockholm, Sweden.
Dominic CampopianoSchool of Chemistry, University of Edinburgh, Edinburgh, EH9 3FJ, UK.
Volker M LauschkeCenter for Molecular Medicine, Karolinska Institute and Karolinska Hospital, 171 76, Stockholm, Sweden.
Maurice MichelDepartment of Oncology and Pathology, Science for Life Laboratory, Karolinska Institute, 171 76, Stockholm, Sweden.ORCID https://orcid.org/0000-0003-3261-2493

Funding

EFPIAInnovative Medicines Initiative 875510Ontario Institute for Cancer ResearchUnion's Horizon 2020 research and innovation programme
6 · The paper itself

Abstract

In this perspective the character of aldehyde functional groups is outlined as central intermediates in DNA repair. As highly reactive entities, aldehydes exist in limited quantities and in contextualized scenarios only and are commonly masked as a Schiff base. Recent advances reveal that principles of organic chemistry can modulate the enzymatic cleavage of Schiff bases, a process termed chemical switching. This approach not only enhances the production of canonical DNA repair products, bolstering cellular function, but also generates novel reaction intermediates, potentially rewiring cellular pathways. However, such rewiring could increase the complexity and toxicity of DNA repair intermediates, influencing therapeutic outcomes. To shape novel classes of therapeutics, an exploitation of these fine-tuned reaction principles requires expertise of enzymologists and scientists skilled in bio- and organocatalysis. Here, the current state of the art is outlined in chemically switching enzymatic function in cells with focus on DNA repair, highlighting challenges of this new type of protein modulation and discussing possible solutions. This paints a picture of the chemical switching concept as an emerging playing field with exciting translational prospects.

Indexed as

AldehydesBiocatalysisCatalysisDNA RepairHumansSchiff BasesAldehydesSchiff BasesbiocatalysisDNA repairenzymologynew modalityorganocatalytic switches

Identifiers

PMID40417833
PMCPMC12135137

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.